SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers

Clinical trial NCT05582122 · RECRUITING

Trial details

NCT number: NCT05582122
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oropharynx Squamous Cell Carcinoma

Start date: 2024-04-03
Primary completion: 2028-04-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.